Martine A. Rothblatt's most recent trade in United Therapeutics Corp was a trade of 9,500 Common Stock done at an average price of $146.0 . Disclosure was reported to the exchange on March 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 05 Mar 2026 | 9,500 | 9,630 (0%) | 0% | 146.0 | 1,387,285 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2026 | 9,500 | 202,000 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 485.00 per share. | 05 Mar 2026 | 2,625 | 2,714 (0%) | 0% | 485.0 | 1,273,121 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 484.05 per share. | 05 Mar 2026 | 1,728 | 5,339 (0%) | 0% | 484.0 | 836,435 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 482.92 per share. | 05 Mar 2026 | 1,293 | 7,067 (0%) | 0% | 482.9 | 624,422 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 487.02 per share. | 05 Mar 2026 | 1,199 | 717 (0%) | 0% | 487.0 | 583,938 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 486.20 per share. | 05 Mar 2026 | 798 | 1,916 (0%) | 0% | 486.2 | 387,990 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 487.98 per share. | 05 Mar 2026 | 587 | 130 (0%) | 0% | 488.0 | 286,445 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 482.05 per share. | 05 Mar 2026 | 510 | 8,360 (0%) | 0% | 482.0 | 245,844 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 480.56 per share. | 05 Mar 2026 | 481 | 8,870 (0%) | 0% | 480.6 | 231,148 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 479.89 per share. | 05 Mar 2026 | 279 | 9,351 (0%) | 0% | 479.9 | 133,889 | Common Stock |
| BETA Technologies Inc | Martine A. Rothblatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 1,071 | 1,071 | - | 0 | Class A common stock | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 4,000 | 2,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 17 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 17 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 4,000 | 6,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 501.35 per share. | 17 Dec 2025 | 2,500 | 130 (0%) | 0% | 501.3 | 1,253,367 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 2,000 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 17 Dec 2025 | 2,000 | 2,130 (0%) | 0% | 120.3 | 240,520 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 507.24 per share. | 17 Dec 2025 | 2,000 | 2,130 (0%) | 0% | 507.2 | 1,014,486 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 507.61 per share. | 17 Dec 2025 | 1,500 | 130 (0%) | 0% | 507.6 | 761,418 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 510.86 per share. | 17 Dec 2025 | 1,500 | 130 (0%) | 0% | 510.9 | 766,295 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 500.52 per share. | 17 Dec 2025 | 1,500 | 2,630 (0%) | 0% | 500.5 | 750,780 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 505.45 per share. | 17 Dec 2025 | 500 | 1,630 (0%) | 0% | 505.5 | 252,725 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 509.42 per share. | 17 Dec 2025 | 500 | 1,630 (0%) | 0% | 509.4 | 254,708 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 15 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 15 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 4,000 | 14,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 4,000 | 10,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 495.14 per share. | 15 Dec 2025 | 3,500 | 130 (0%) | 0% | 495.1 | 1,732,984 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 492.49 per share. | 15 Dec 2025 | 2,500 | 1,630 (0%) | 0% | 492.5 | 1,231,235 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 494.00 per share. | 15 Dec 2025 | 1,000 | 630 (0%) | 0% | 494 | 494,000 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 497.17 per share. | 15 Dec 2025 | 500 | 130 (0%) | 0% | 497.2 | 248,585 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 491.77 per share. | 15 Dec 2025 | 500 | 3,630 (0%) | 0% | 491.8 | 245,885 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2025 | 4,000 | 22,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2025 | 4,000 | 18,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 11 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 11 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 490.98 per share. | 11 Dec 2025 | 2,900 | 130 (0%) | 0% | 491.0 | 1,423,834 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 484.30 per share. | 11 Dec 2025 | 1,976 | 654 (0%) | 0% | 484.3 | 956,984 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 483.12 per share. | 11 Dec 2025 | 1,500 | 2,630 (0%) | 0% | 483.1 | 724,682 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 489.95 per share. | 11 Dec 2025 | 1,100 | 3,030 (0%) | 0% | 490.0 | 538,949 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 485.14 per share. | 11 Dec 2025 | 524 | 130 (0%) | 0% | 485.1 | 254,213 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 5,000 | 10,962 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 08 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 4,000 | 30,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 4,000 | 26,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 08 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 477.63 per share. | 08 Dec 2025 | 2,440 | 1,690 (0%) | 0% | 477.6 | 1,165,422 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 480.17 per share. | 08 Dec 2025 | 1,600 | 1,530 (0%) | 0% | 480.2 | 768,272 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 479.33 per share. | 08 Dec 2025 | 1,560 | 130 (0%) | 0% | 479.3 | 747,762 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 477.92 per share. | 08 Dec 2025 | 1,000 | 3,130 (0%) | 0% | 477.9 | 477,920 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 481.72 per share. | 08 Dec 2025 | 1,000 | 130 (0%) | 0% | 481.7 | 481,715 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 480.71 per share. | 08 Dec 2025 | 400 | 1,130 (0%) | 0% | 480.7 | 192,284 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 05 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2025 | 4,000 | 34,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2025 | 4,000 | 38,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 05 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 482.94 per share. | 05 Dec 2025 | 3,000 | 1,130 (0%) | 0% | 482.9 | 1,448,810 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 484.55 per share. | 05 Dec 2025 | 1,092 | 1,030 (0%) | 0% | 484.5 | 529,128 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 482.23 per share. | 05 Dec 2025 | 1,008 | 3,122 (0%) | 0% | 482.2 | 486,091 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 482.92 per share. | 05 Dec 2025 | 1,000 | 2,122 (0%) | 0% | 482.9 | 482,920 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 484.31 per share. | 05 Dec 2025 | 1,000 | 130 (0%) | 0% | 484.3 | 484,310 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 488.97 per share. | 05 Dec 2025 | 500 | 130 (0%) | 0% | 489.0 | 244,485 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 485.78 per share. | 05 Dec 2025 | 400 | 630 (0%) | 0% | 485.8 | 194,312 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 03 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2025 | 4,000 | 42,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2025 | 4,000 | 46,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 03 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 480.60 per share. | 03 Dec 2025 | 2,595 | 130 (0%) | 0% | 480.6 | 1,247,151 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 476.26 per share. | 03 Dec 2025 | 1,640 | 130 (0%) | 0% | 476.3 | 781,063 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 474.10 per share. | 03 Dec 2025 | 1,500 | 2,630 (0%) | 0% | 474.1 | 711,152 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 478.93 per share. | 03 Dec 2025 | 1,405 | 2,725 (0%) | 0% | 478.9 | 672,893 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 475.43 per share. | 03 Dec 2025 | 860 | 1,770 (0%) | 0% | 475.4 | 408,873 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 01 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 4,000 | 50,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 4,000 | 54,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 01 Dec 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 482.95 per share. | 01 Dec 2025 | 1,731 | 130 (0%) | 0% | 483.0 | 835,989 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 480.28 per share. | 01 Dec 2025 | 1,590 | 2,540 (0%) | 0% | 480.3 | 763,638 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 482.28 per share. | 01 Dec 2025 | 1,390 | 1,150 (0%) | 0% | 482.3 | 670,368 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 478.64 per share. | 01 Dec 2025 | 1,000 | 3,130 (0%) | 0% | 478.6 | 478,640 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 481.72 per share. | 01 Dec 2025 | 769 | 1,861 (0%) | 0% | 481.7 | 370,443 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 483.38 per share. | 01 Dec 2025 | 520 | 630 (0%) | 0% | 483.4 | 251,358 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 480.14 per share. | 01 Dec 2025 | 500 | 2,630 (0%) | 0% | 480.1 | 240,070 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 484.68 per share. | 01 Dec 2025 | 500 | 130 (0%) | 0% | 484.7 | 242,340 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 4,000 | 62,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 26 Nov 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 26 Nov 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 4,000 | 58,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 484.45 per share. | 26 Nov 2025 | 2,134 | 1,996 (0%) | 0% | 484.4 | 1,033,816 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 487.30 per share. | 26 Nov 2025 | 1,609 | 1,721 (0%) | 0% | 487.3 | 784,058 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 485.24 per share. | 26 Nov 2025 | 1,366 | 630 (0%) | 0% | 485.2 | 662,838 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 488.36 per share. | 26 Nov 2025 | 1,091 | 630 (0%) | 0% | 488.4 | 532,797 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 485.71 per share. | 26 Nov 2025 | 800 | 3,330 (0%) | 0% | 485.7 | 388,570 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 490.25 per share. | 26 Nov 2025 | 500 | 130 (0%) | 0% | 490.3 | 245,125 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 487.10 per share. | 26 Nov 2025 | 500 | 130 (0%) | 0% | 487.1 | 243,550 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 24 Nov 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 24 Nov 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 4,000 | 66,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 4,000 | 70,000 | - | - | Stock Option |